Structural basis for inhibition of the Hsp90 molecular chaperone by the antitumor antibiotics radicicol and geldanamycin.
Open accessThe DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
The cellular activity of several regulatory and signal transduction proteins, which depend on the Hsp90 molecular chaperone for folding, is markedly decreased by geldanamycin and by radicicol (monorden). We now show that these unrelated compounds both bind to the N-terminal ATP/ADP-binding domain of Hsp90, with radicicol displaying nanomolar affinity, and both inhibit the inherent ATPase activity of Hsp90 which is essential for its function in vivo. Crystal structure determinations of Hsp90 N-terminal domain complexes with geldanamycin and radicicol identify key aspects of their nucleotide mimicry and suggest a rational basis for the design of novel antichaperone drugs.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
MOLSCRIPT: a program to produce both detailed and schematic plots of protein structures
Kraulis, P. J. (1991) · Journal of Applied Crystallography · doi:10.1107/s0021889891004399 · Cited by 14,085
LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions
Wallace, A. C., Laskowski, R. A., & Thornton, J. M. (1995) · "Protein Engineering, Design and Selection" · doi:10.1093/protein/8.2.127 · Cited by 5,690
Whitesell, L., Mimnaugh, E. G., De Costa, B., Myers, C. E., & Neckers, L. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.18.8324 · Cited by 1,444
Stebbins, C. E., Russo, A. A., Schneider, C., Rosen, N., Hartl, F. U., & Pavletich, N. P. (1997) · Cell · doi:10.1016/s0092-8674(00)80203-2 · Cited by 1,364
Prodromou, C., Roe, S. M., O'Brien, R., Ladbury, J. E., Piper, P. W., & Pearl, L. H. (1997) · Cell · doi:10.1016/s0092-8674(00)80314-1 · Cited by 1,265
Self-citationDynamic activation of endothelial nitric oxide synthase by Hsp90
García-Cardeña, G., Fan, R., Shah, V., Sorrentino, R., Cirino, G., Papapetropoulos, A., & Sessa, W. C. (1998) · Nature · doi:10.1038/33934 · Cited by 1,029
ATP binding and hydrolysis are essential to the function of the Hsp90 molecular chaperone in vivo
Panaretou, B., Prodromou, C., Roe, S. M., O'Brien, R., Ladbury, J. E., Piper, P. W., & Pearl, L. H. (1998) · The EMBO Journal · doi:10.1093/emboj/17.16.4829 · Cited by 735
Self-citationGrenert, J. P., Sullivan, W. P., Fadden, P., Haystead, T. A. J., Clark, J., Mimnaugh, E., Krutzsch, H., Ochel, H.-J., Schulte, T. W., Sausville, E., et al. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.38.23843 · Cited by 569
Preclinical pharmacologic evaluation of geldanamycin as an antitumor agent
Supko, J. G., Hickman, R. L., Grever, M. R., & Malspeis, L. (1995) · Cancer Chemotherapy and Pharmacology · doi:10.1007/bf00689048 · Cited by 510
Joab, I., Radanyi, C., Renoir, M., Buchou, T., Catelli, M.-G., Binart, N., Mester, J., & Baulieu, E.-E. (1984) · Nature · doi:10.1038/308850a0 · Cited by 434
Research works printed but not linked: 15
- Kwon H. J., 1992, Biosci. Biotechnol. Biochem., 56, 539
- Zhao J. F., 1995, Oncogene, 11, 173
- Kwon H. J., 1995, J. Biochem., 118, 228
- Fukazawa H., 1991, Biochem. Pharmacol., 42, 1671
- Smith D. F., 1995, Mol. Cell. Biol., 15, 6812
- Whitesell L., 1996, Endocrinology, 10, 712
- Ali J. A., 1993, Biochemistry, 32, 2724
- Cutler H. G., 1987, Agric. Biol. Chem., 51, 3338
- Schnur R. C., 1995, J. Med. Chem., 38, 3820
- Schnur R. C., 1995, J. Med. Chem., 38, 3812
- Hartmann F., 1997, Int. J. Cancer, 70, 229, 10.1002/(SICI)1097-0215(19970117)70:2<221::AID-IJC14>3.0.CO;2-L · doi:10.1002/(sici)1097-0215(19970117)70:2<221::aid-ijc14>3.0.co;2-l
- Dai K., 1996, J. Biol. Chem., 271, 22034
- Whitesell L., 1992, Cancer Res., 52, 1728
- Prodromou C., 1996, PROTEINS: Struct. Funct. Genet., 25, 522
- Merrit E. A., 1994, Acta Crystallogr., 50, 873
Cited by
Items 901–1,000 of 1,000
Drug Metabolism Determines Resistance of Colorectal Cancer to Resorcinol-Based HSP90 Inhibitors
Landmann, H. (2014) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-4762 · Cited by 1
Withaferin A Targets Hsp90 in Pancreatic Cancer Cells.
Yu, Y. (2011) · Deep Blue (University of Michigan) · Cited by 1
Youker, R. T. (2006) · D-Scholarship@Pitt (University of Pittsburgh) · Cited by 1
Drugging the Hsp90 molecular chaperone machine for cancer treatment
Holmes, J. L., Sharp, S. Y., & Workman, P. (2007) · Springer eBooks · doi:10.1007/978-1-4020-6401-2_15 · Cited by 1
Cell Proliferation: From Signal Transduction to Cell Cycle
Yoshida, M. (2000) · Springer eBooks · doi:10.1007/978-4-431-65927-3_2
Njardarson, J. T., Garbaccio, R. M., & Danishefsky, S. J. (2003) · Wiley eBooks · doi:10.1002/9783527619481.ch24
Pharmacokinetics, Pharmacodynamics, and Formulation Development of Hydrophobic Xenobiotics
Remsberg, C. M. (2011) · Research Exchange (Washington State University)
II. Participación del óxido nítrico en la fisiopatología cardiovascular
Pastelín-Hemández, G., del Valle‐Mondragón, L., López, F. A. T., & Torres-Narváez, J. C. (2007) · Gaceta Médica de México
Ricart, K. C. (2010) · Repositorio Digital Institucional de la Universidad de Buenos Aires (Universidad de Buenos Aires) · Cited by 1
The Hsp 90 Family of Molecular Chaperones
Richter, K., Meinlschmidt, B., & Büchner, J. (2008) · Wiley eBooks · doi:10.1002/9783527610754.sf22
Chapter 2 Synthesis of geldanamycin using glycolate aldol reactions
Andrus, M. B., Hicken, E. J., & Meredith, E. L. (2005) · Strategies and tactics in organic synthesis · doi:10.1016/s1874-6004(05)80025-5
The cytosolic fate of ricin A chain in target cells
Hart, P. J. (2026) · Warwick Research Archive Portal (University of Warwick) · doi:10.82444/warw.33594793
Data on Small Molecules and their Target Proteins
Usui, T., Saito, A., & Osada, H. (2009) · Wiley eBooks · doi:10.1002/9780470495018.ch12
Hrizo, S. (2008) · D-Scholarship@Pitt (University of Pittsburgh)
17-AAG and sihsp90α combinational therapy as a novel anti-cancer approach
Mehta, A. (2012) · CLOK (University of Central Lancashire)
Conte, T. C. (2009) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.42.2009.tde-26012010-111321
Five‐Membered Heterocyclic Rings and Their Fused Derivatives
Diana, P., & Cirrincione, G. (2015) · Wiley eBooks · doi:10.1002/9781118960554.ch5
Wochnik, G. M. (2004) · Electronic Theses of LMU Munich (Ludwig-Maximilians-Universität München) · doi:10.5282/edoc.2498 · Cited by 1
ANDROGEN RECEPTOR IN TRANSCRIPTIONAL REGULATION AND CARCINOGENESIS
Kang, Z. (2006) · Helda - University of Helsinki Institutional Repository
protein interactions without immobilization or chemical derivatization
Vuckovic, D., Sleno, L., Olsen, J. B., Pogoutse, O., Havugimana, P. C., Hewel, J. A., Bajaj, N., Wang, Y., Musteata, F. M., Nislow, C., et al. (2012)
Emerging drugs in B-cell non-Hodgkin's lymphoma
Kassam, S., & Montoto, S. (2008) · Expert Opinion on Emerging Drugs · doi:10.1517/14728210802002780
Yang, L. (2005) · D-Scholarship@Pitt (University of Pittsburgh)
Jiménez, M. F. T. (2013) · UKnowledge (University of Kentucky)
THE ROLE OF HSPs IN MHC CLASS II PRESENTATION OF SELECT ANTIGENS
Houlihan, J. L. (2010) · IUScholarWorks (Indiana University) · doi:10.7912/c2/1695
Cell Cycle Regulators as Targets of Anticancer Therapy
Blagosklonny, M. V. (2003) · Humana Press eBooks · doi:10.1007/978-1-59259-401-6_10
Regulation of protein kinase TAK1
Liu, X. (2009) · DR-NTU (Nanyang Technological University) · doi:10.32657/10356/42238
Chemistry and Pharmacognosy of the Genus Durio
Rudiyansyah, R., Panthong, K., & Garson, M. J. (2015) · Natural Product Communications · doi:10.1177/1934578x1501001115 · Cited by 4
Exploiting the Dependency of Cancer Cells on Molecular Chaperones
Sharp, S. Y., Howes, J. E., & Workman, P. (2013) · Royal Society of Chemistry eBooks · doi:10.1039/9781849739689-00126
Brough, P. A., Schoepfer, J. G., Massey, A. J., & Jensen, M. R. (2013) · Royal Society of Chemistry eBooks · doi:10.1039/9781849739689-00213
Discovery and Development of Ganetespib
Ying, W. (2013) · Royal Society of Chemistry eBooks · doi:10.1039/9781849739689-00180
Molecular Recognition and Its Importance for Fragment‐Based Lead Generation and Hit‐to‐Lead
Nowak, T. (2016) · Methods and principles in medicinal chemistry · doi:10.1002/9783527677047.ch13
Hsp90: Common Target for Diverse Antibiotics
Kalyanaraman, P. (2006) · SHAREOK (University of Oklahoma; Oklahoma State University; Central Oklahoma University)
Munje, C. (2011) · CLOK (University of Central Lancashire)
Allosteric Modulators of Heat Shock Protein 90 (HSP90)
Koay, Y. C., & McAlpine, S. R. (2016) · Royal Society of Chemistry eBooks · doi:10.1039/9781782629276-00404
Xu, Y. (2016) · DukeSpace (Duke University)
Schwock, J. (2010) · TSpace (University of Toronto)
Targeting Hsp90 Function to Treat Cancer: Much More to Be Learned
Whitesell, L. J., & McLellan, C. A. (2007) · Springer eBooks · doi:10.1007/978-1-4020-6401-2_13
The Roles of Hsp90 and Calcineurin in Antifungal Drug Resistance
Singh, S. (2012) · TSpace (University of Toronto)
Armstrong, H. (2013) · ERA: Education and Research Archive (University of Alberta) · doi:10.7939/r3tc7r
Morrison, L. J., Alter, J. S., Ginsburg, M., Marx, J. H., & Blee, K. M. (2003)
Automatic assignment of methyl resonances using experimental NMR data and graph theory
Pritišanac, I. (2016) · Oxford University Research Archive (ORA) (University of Oxford) · doi:10.5287/ora-6rbgopxgj
Heat Shock Protein 90 Inhibitors in Lung Cancer Therapy
Chatterjee, S., & Burns, T. F. (2019) · Heat shock proteins · doi:10.1007/978-3-030-03952-3_19
Acción biológica de la inmunofilina de alto peso molecular FKBP51 en procesos malignos
Zgajnar, N. R. (2017) · Repositorio Digital Institucional de la Universidad de Buenos Aires (Universidad de Buenos Aires)
Role of Heat Shock Protein 90 in Mammary Tumorigenesis
Kumar, B. V. S., Gopal, P. K., & Verma, R. (2019) · Heat shock proteins · doi:10.1007/978-3-030-23158-3_5
p53-Hsp90 Axis in Human Cancer
Ghaleb, A. M., & Marchenko, N. D. (2019) · Heat shock proteins · doi:10.1007/978-3-030-23158-3_7
Abu‐Zaid, A., Singh, S. V., Lin, W., Low, J. A., Abdolvahabi, A., Cooke, B., Bowling, J. J., Vaithiyalingam, S., Fang, J., Currier, D. G., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2019.12.11.872838
Defined Interactions of Protein Kinases with Hsp90 and Cdc37
Prince, T. L. (2005) · SHAREOK (University of Oklahoma; Oklahoma State University; Central Oklahoma University)
Hofmann, T. (2009) · Repository for Publications and Research Data (ETH Zurich) · doi:10.3929/ethz-a-005826434
Rao, A. (2012) · D-Scholarship@Pitt (University of Pittsburgh)
Welch, M. D. (2008) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.1131951.589060
Blagg, B. S. J., & Hadden, M. K. (2010) · Wiley eBooks · doi:10.1002/0471266949.bmc212
Blagg, B. S. J., Hadden, M. K., & Tarpley, R. S. (2021) · Wiley eBooks · doi:10.1002/0471266949.bmc212.pub2
Three‐Membered Heterocyclic Rings and Their Fused Derivatives
Diana, P., & Cirrincione, G. (2015) · Wiley eBooks · doi:10.1002/9781118960554.ch3
Overcoming Cisplatin Resistance in Pancreatic Cancer
Ewers, K. M. (2021) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-8945
Beljanski, V. (2007) · Elsevier eBooks · doi:10.1016/b978-008055232-3.63582-2
Zierer, B. K., & Büchner, J. (2012) · Wiley eBooks · doi:10.1002/9780470015902.a0024154
Mollapour, M. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.737482045.793572272
Gallie, D. (2007) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.1098604.554709
3D-QSAR and Docking Studies on Pyrimidine Derivatives of Second-Generation ALK Inhibitors
Jiang, G.-L., Song, L.-H., Qiu, Y.-F., & Liu, Y. (2022) · Pharmaceutical Fronts · doi:10.1055/s-0042-1750044
Secondary metabolites of fungus Thyronectria sp. and their antifungal and anticancer activities
Alilou, M., Mottaghipisheh, J., Gelbrich, T., Peintner, U., Troppmair, J., & Stuppner, H. (2022) · Planta Medica · doi:10.1055/s-0042-1759017
Modulation of HSF1 activity by p53 and its impact in cancer therapies
Isermann, T. (2023) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-9996
Distinguishing mutants that resist drugs via different mechanisms by examining fitness tradeoffsPreprint
Schmidlin, K., Apodaca, S., Newell, D., Sastokas, A., Kinsler, G., & Geiler‐Samerotte, K. (2024) · eLife · doi:10.7554/elife.94144.2
Schmidlin, K., Apodaca, S., Newell, D., et al. (2024) · eLife · doi:10.7554/elife.94144.2.sa1
Schmidlin, K., Apodaca, S., Newell, D., Sastokas, A., Kinsler, G., & Geiler‐Samerotte, K. (2024) · eLife · doi:10.7554/elife.94144.2.sa0
Unexpected proteins involved in the regulation of secondary metabolism in Myxococcus xanthus DK1622
Izzat, S., Abdullah, S. M., Sabir, M. N., Wei, W., Ye, B., & Rachid, S. (2024) · Biotechnology and Applied Biochemistry · doi:10.1002/bab.2682
FLEXR-MSA : electron-density map comparisons of sequence-diverse structures
Stachowski, T. R., & Fischer, M. M. (2025) · IUCrJ · doi:10.1107/s2052252525001332
Jeanne, X., Oberoi, J., Roe, S. M., Baud, M. G. J., Spencer, J., Török, Z., Vígh, L., & Prodromou, C. (2025) · Cell Stress and Chaperones · doi:10.1016/j.cstres.2025.100131
Self-citationTurbyville, T. J. (2005) · UA Campus Repository (The University of Arizona)
A Novel HSP90 Inhibitor to Disrupt HSP90/p50CDC37 Complex for Pancreatic Cancer Therapy.
Zhang, T. (2011) · Deep Blue (University of Michigan)
RNA Interference by the Numbers: Explaining Biology Through Enzymology: A Dissertation
Wee, L. M. (2013) · The Journal of the American Medical Association (JAMA) Network (American Medical Association) · doi:10.13028/m2pc85
Cheng, X.-F., He, S.-T., Zhong, G., Meng, J.-J., Wang, M., Bi, Q., & Tu, R.-H. (2024) · Figshare · doi:10.6084/m9.figshare.26565426
Prokofeva, P., Küster, B., & München, T. U. (2023)
Xue, A. (2022) · TSpace (University of Toronto)
Schroyer, A. L. (2017) · OhioLink ETD Center (Ohio Library and Information Network)
Pageau, A. (2023) · Corpus Université Laval (Université Laval)
Development of Fungal-selective Molecules and Strategies to Target Hsp90
LeBlanc, E. V. (2020) · TSpace (University of Toronto)
Li, Y., Xie, H., Zhuang, Z., Fang, X., Yang, W., Luo, Y., Hu, J., Wang, W., Wang, H., Dou, X., et al. (2026) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2026.178775
C-H fonctionnalisation de purines : synthèse d’inhibiteurs potentiels de la HSP90
Sahnoun, S. (2011) · theses.fr (ABES) · doi:10.70675/39de54cdzed42z410bz84c5zaf41b61046db
Rôle des protéines de choc thermique dans la régulation du facteur de transcription HIF
Maurel, S. (2011) · theses.fr (ABES) · doi:10.70675/6c4976d2z7255z47e2z858dza726580d0af4
Formation et régulation du complexe polymérase du virus de la rougeole
Bloyet, L.-M. (2015) · theses.fr (ABES) · doi:10.70675/39007b42zbb49z41b5zb5ffz4d00c60c4b16
La protéine HSP90 : expression et ciblage dans les hémopathies malignes
Flandrin‐Gresta, P. (2012) · theses.fr (ABES) · doi:10.70675/c7c4c69bz12d5z4cc5zad16z0af4fefb9fb8
Mshaik, R. (2021) · theses.fr (ABES) · doi:10.70675/305ed268za5abz4fe0zab3az8edd307bdf05 · Cited by 1
Machine Learning Methods for Molecular Dynamic Simulations
Belkacemi, Z. (2022) · theses.fr (ABES) · doi:10.70675/df72a073z4c4az496czad04z5eb4bd2c58c4
Petraška, V., Griškonytė, G., Neverdauskas, L., Gedgaudas, M., Brukstus, A., Kazlauskas, E., & Žutautė, I. (2026) · Archiv der Pharmazie · doi:10.1002/ardp.70232
Wang, W. L., Li, S., Cai, Y., Chen, Y., Zhu, J., & Jin, J. (2026) · Chemical Research in Chinese Universities · doi:10.1007/s40242-026-6078-0
Metadata
- Authors
- Roe, S. M., Prodromou, C., O'Brien, R., Ladbury, J. E., Piper, P. W., & Pearl, L. H.
- Affiliations
- University College London (GB)
- Department of Biochemistry and Molecular Biology, University College London, Gower Street, London WC1E 6BT, U.K.
- Venue
- Journal of Medicinal Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 1999-01-01
- Volume
- 42
- Issue
- 2
- Pages
- 260-266
- ISSN
- 0022-2623 (ISSN-L)
- 1520-4804
- OpenAlex
- W2042699875
- Cited by
- 1,004
- References
- 26
- Citations by year
- 2026: 12 · 2025: 23 · 2024: 25 · 2023: 17 · 2022: 24 · 2021: 23 · 2020: 38 · 2019: 45 · 2018: 32 · 2017: 23 · 2016: 35 · 2015: 43 · 2014: 47 · 2013: 31 · 2012: 50
- FWCI
- 8.96
- Type
- journal article
- Language
- en
- Open access
- green
- figshare.com
- Licence
- cc-by
- Locations
- Journal of Medicinal Chemistry (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- Funders
- Wellcome Trust
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Structure and Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Biochemical and Molecular Research
- Keywords
- HSP90, molecular chaperones, geldanamycin, radicicol, antitumor antibiotics, ATPase inhibition, protein folding
- MeSH terms
- Adenosine Diphosphate, Adenosine Triphosphatases, Antibiotics, Antineoplastic, Calorimetry, Lactones, Models, Molecular, Quinones, Structure-Activity Relationship, Benzoquinones, Crystallography, X-Ray, Molecular Mimicry, HSP90 Heat-Shock Proteins, Macrolides, Lactams, Macrocyclic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.